Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

7177-50-6

Nafcillin sodium monohydrate

7177-50-6
55134-13-9

Narasin

55134-13-9
487-19-4

Nicotyrine beta

487-19-4
389-08-2

Nalidixic acid

389-08-2
70253-62-2

Neospiramycin

70253-62-2
550-99-2

Naphazoline HCl

550-99-2
93413-77-5

N,N-Didesmethylvenlafaxin

93413-77-5
149289-30-5

N-Desmethylvenlafaxin

149289-30-5
127-74-2

N4-Acetylsulfadiazin

127-74-2
24341-30-8

N4-Acetyl-sulfadimethoxin

24341-30-8
21312-10-7

N4-Acetyl-sulfamethoxazol

21312-10-7
130194-43-3

(R)-Norfluoxetine

130194-43-3
146-22-5

Nitrazepam

146-22-5
29790-52-1

Nicotine Salicylate

29790-52-1
1476-53-5

Novobiocin sodium salt

1476-53-5
797-63-7

(-)-Norgestrel

797-63-7
68-22-4

Norethindrone (Norethisterone)

68-22-4
1847-63-8

Nafoxidine HCl

1847-63-8
965-52-6

Nifuroxazide

965-52-6
52079-10-4

O-Desmethyl Naproxen

52079-10-4